Clinical pharmacogenetics of irinotecan (CPT-11)

被引：0
|
作者：
Ando, Y [1 ]
机构：
[1] Saitama Med Sch, Dept Clin Oncol, Moroyama, Saitama 3500495, Japan
来源：
DRUG METABOLISM REVIEWS | 2004年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
32
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [1] Clinical pharmacogenetics of irinotecan (CPT-11)
    Ando, Y
    Hasegawa, Y
    [J]. DRUG METABOLISM REVIEWS, 2005, 37 (03) : 565 - 574
  • [2] Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)
    Mathijssen, RHJ
    van Alphen, RJ
    Verweij, J
    Loos, WJ
    Nooter, K
    Stoter, G
    Sparreboom, A
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (08) : 2182 - 2194
  • [3] Irinotecan (CPT-11): Pharmacology and clinical applications
    Masuda, N
    Kudoh, S
    Fukuoka, M
    [J]. CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1996, 24 (01) : 3 - 26
  • [4] Future directions for clinical research with CPT-11 (irinotecan)
    VonHoff, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A : S9 - S12
  • [5] Irinotecan (CPT-11) for multiple myeloma
    Yano, H.
    Iida, S.
    Kayukawa, S.
    Nakagawa, C.
    Oguri, T.
    Ri, M.
    Inagaki, A.
    Sanda, T.
    Kusumoto, S.
    Ishida, T.
    Komatsu, H.
    Suzuki, A.
    Ueda, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 140 - 140
  • [6] Irinotecan (CPT-11): A brief overview
    Rivory, LP
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (10-11) : 1000 - 1004
  • [7] Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma
    Le, DT
    Deavers, M
    Hunt, K
    Malpica, A
    Verschraegen, CF
    [J]. CANCER INVESTIGATION, 2003, 21 (05) : 682 - 689
  • [8] The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11)
    Dodds, HM
    Rivory, LP
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1346 - 1353
  • [9] Synthesis of CPT-11 (irinotecan hydrochloride trihydrate)
    Sawada, S
    Yokokura, T
    Miyasaka, T
    [J]. CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT, 1996, 803 : 13 - 28
  • [10] Irinotecan (CPT-11) in the treatment of mycosis fungoides
    Yokote, T
    Akioka, T
    Oka, S
    Yamano, T
    Hara, S
    Higashi, K
    Enomoto, U
    Kusakabe, H
    Kiyokane, K
    Tsuji, M
    Hanafusa, T
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (05) : 1086 - 1088
12345